Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

B1omed - Drugs: from molecules to man > Module 1 > Flashcards

Module 1 Flashcards

You may prefer our related Brainscape-certified flashcards:
Organic Chemistry 101 flashcards
1
Q

Pre-scientific era: what remedies were used, where were they obtained, and what was the knowledge for them?

A

Morphine, aspirin, alcohol, cocaine

Natural sources

  • Mechanisms unknown
  • Side effects not widely recognised
  • Structure of the drug and target is unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Cocaine in the 19th century: how accessible was it, was it understood, and where was it used?

A

Uncontrolled, available from grocery stores

Mechanism not understood

Included in patent medicines

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What was cocaine used to treat?

A

Freud said:

  • Mental stimulant
  • Treatment for digestive
  • Disorders
  • Appetite stimulant
  • Treatment for morphine addiction
  • Treatment for asthma
  • Aphrodisiac
  • Local anaesthetic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The regulation of cocaine as an anaesthetic throughout time

A

Early 1900s: regulation

  • Procaine synthesised 1905 (Einhorn)
  • Tetracaine 1941
  • Lidocaine 1943
    (Cocaine still used though)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What did Paul Ehrlich research and what synthetic drug did he make?

A
  • Research on sleeping sickness
  • Tested >900 arsenical compounds
  • 1909 #606 tested on syphilis
  • Completely effective
  • Released 1910: Salvarsan
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

The three ways that drugs can be discovered

A

Natural sources (Cocaine, Aspirin)
Synthetically produced (Salvarsan)
Serenpidity (Penicillin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Pharmacology, pharmacodynamics, and pharmacokinetics: what do they all mean?

A
  • Actions of drugs on living organisms
  • The mechanisms of drug action
  • The handling of drugs by body use of drugs as scientific tools (?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What do drugs target and what are the examples of the exceptions?

A

Proteins

Exceptions:
* Antacids
* Osmotic diuretics (reduce intracranial pressure)
* DNA modifying drugs (cancer therapy)
* Drugs that target membrane lipids (some antibiotics)

Interactions with the exceptions tend to be non-saturable, with little specificity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Relative sizes of drugs and receptors

A

Drugs are usually quite small (<500 Da) in comparison to the receptors (100s of kDa)

This general rule does not apply to protein-based drugs like monoclonal antibodies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Drug binding domains: what are they, and what issues may arise if mutations occur in this area?

A

The cavity in the receptor which allows things (like drugs) to bind given that they can attach to and cope with the chemical environment caused by its amino acids

If a mutation occurs affecting only the binding domain, then the general shape and structure of the receptor may be the same, but drugs (and other binders) may not be able to bind and so that function is lost

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What does the binding energy of a drug binding to a protein do?

A

When the drug binds to a receptor, the binding energy released will either be stabilised in a particular conformation or may cause a conformational change

The conformational change of the protein causes the drug’s effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Protein superfamilies: what are they and what causes their grouping?

A

Massive groups containing large amounts of proteins

These are grouped together based on similar structure, function, and gene sequence

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

CNS, muscle, heart, and DRG: what can mutations to sodium channels in these areas cause?

A

CNS: epilepsy
Muscle: myotonia, paralysis
Heart: rhythm disorders
DRG: insensitivity to pain, chronic pain, or psychological disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Target diversity: what is it and how can it be exploited?

A

Target diversity is an issue as some drugs may bind to two different types of proteins as some proteins are very closely related and have very similar amino acid sequences.

This can be exploited by synthetically altering drugs to not bind to any other proteins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Endogenous

A

Originating within the organism (hormone, neurotransmitter)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Exogenous

A

Originating from outside the organism (light, pressure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Receptor: what is the definition and what are the types?

A

A receptor is a protein that interacts with an information-carrying stimulus and passes the information into a different form (either affecting the cell or passing the info further)

TRK, NHR, GPCRs, and LGIC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Acetylcholinesterase: is it counted as a receptor?

A

No, although it binds to acetylcholine, it breaks it down so it counts as an enzyme

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

RTK: what do they do, what do they bind to, where are they located, how many are there in the human genome, what are examples, and what are the key characteristics?

A

Receptor tyrosine kinase phosphorylates tyrosine residues in proteins, altering the protein’s effect and causing a specific result to occur

They bind to peptide hormones and growth factors mainly

Transmembrane

58 transmembrane proteins

Insulin receptors

  • May exist as monomers but the functional unit is in a dimeric form
20
Q

LGIC: what do they do, where are they located, what are examples, and what are the key characteristics?

A

Ligand-gated ionic channels change the membrane potential after two agonists bind to two receptor sites and open the channel

Transmembrane

Nicotinic-acetylcholine receptors

  • They are all multisubunit receptors
  • Can allow fast signalling
  • Several structurally different types
21
Q

GPCR: what do they do, where are they located, how many are there in the human genome, what are examples, and what are the key characteristics?

A

G-protein coupled receptors act with paired proteins (G proteins) and use these proteins to influence cell activity via other proteins

Membrane - 7 transmembrane domain structure

The biggest family of receptors - 831 genes

β₂ adrenoreceptors

  • Important in olfactory, vision, and nervous system
  • Act via G-proteins (cAMP/IP3/PIP₂/PLC)
22
Q

NHR: what do they do, what do they bind to, where are they located, how many are there in the human genome, what are examples, and what are the key characteristics?

A

Nuclear hormone receptors are activated when their agonist enters the cell and binds. The NHR then binds to DNA and affects gene expression by transgression or transactivation

Lipid-soluble ligands (ie steroids)

Intracellular locations

48 receptors

Glucocorticoid receptors

  • Effects tend to be slower than other receptors (hours to days)
23
Q

The worldwide effect of GCPRs: how many drugs target them, what are the annual sales of their drug targets, and how many targets are there?

A

34% of drugs

> $180 billion

170 drug targets

24
Q

Examples of conditions where drugs target GPCR and the drugs used to treat them

A
  • Depression: Antidepressants (indirectly)
  • Schizophrenia, bipolar disorder: antipsychotics (dopamine D2 receptor)
  • Asthma: salbutamol (beta 2 AdR)
  • Blood pressure: losartan (Cozaar), atenolol
  • Glaucoma: pilocarpine (muscarinic receptors)
  • Abuse: analgesics (cannabis, heroin, LSD)
25
Q

The general structure of GPCRs

A

7 transmembrane domains

NH₂ terminus outside the cell

(Same structure of bacteriorhodospin)

26
Q

Diversity of GPCR

A

Muscarinic receptors: M1-M5
Adrenergic receptors: α₁, α₂, β₁, and β₂

Nicotinoid acetylcholine receptors - not GPCR, VGIC

27
Q

The four parts of a GPCR

A
  • An agonist ligand
  • Membrane-bound GPCR
  • G-protein (guanine nucleotide-binding protein) binds to a GTP/GDP as a trimeric membrane protein
  • A protein (usually an enzyme) that acts as a secondary messenger
28
Q

The GPCR activation cycle

A

Step 1: A G-protein has a GDP attached to it

Step 2: An agonist binds to the GPCR, allowing the G-protein to attach and swap its GDP for a GTP

Step 3: The binding of GTP splits the G-protein into the α subunit with the GTP attached and the β and γ subunits

Both of these subunits will pass the message onto more target proteins

Step 4: The α subunit has GTPase so will eventually hydrolise GTP into GDP + Pi, resetting the signalling process

29
Q

Why is the GPCR signalling cycle referred to as a cascade process?

A

One agonist gives the message to one receptor which gives the message to multiple G-proteins which give the message to a higher number of target receptors

(It’s an amplification process)

30
Q

Heterotrimeric proteins

A

Contain an α-subunit, a βγ complex, a bound GDP, and lipids that are added post-translation

31
Q

Types of α-subunits

A

Gi proteins:
Gᵢ/α₀, αᵢ, α₀ - inhibition of adenyl cyclase (AC)
Gₜ, αₜ (transducin) - activation PDE 6 (vision)
G₉, α₉ᵤₛₜ (gustducin) - activation PDE-6 (taste)

Gs proteins:
Gₛ, αₛ - activation of AC
Gₒₗբ, αₒₗբ - activation of AC (olfaction)

Gq proteins:
Gq, αq - activation of phospholipase C

32
Q

Receptor coupled to Gs

A
  • β-adrenoceptors
  • Dopamine receptors D1 and D5
  • Glucagon receptor
  • Cannabinoid receptor CB2
  • Histamine H2 receptor
  • Luteinizing hormone receptor
  • Follicle-stimulating hormone receptor

All activating/stimulating receptors

33
Q

The function of Gs in the cAMP pathway

A

Gs gets activated by a GCPR and it swaps its GDP for a GTP which causes the α subunit to dissociate and bind to adenyl cyclase and stimulate the conversion of ATP into cAMP which binds to PKA and activates for whatever function

34
Q

The function of Gi in the cAMP pathway

A

Gi gets activated by a GPCR and it swaps GDP for a GTP which causes the α subunit to dissociate and bind to adenyl cyclase and inhibit its action, causing less ATP to convert into cAMP, and inhibiting PKA production, reducing the effect of PKA

35
Q

Receptors associated with Gi proteins

A
  • Muscarinic acetylcholine receptors M2 and M4
  • Cannabinoid receptors CB1 and CB2
  • Dopamine D2, D3 and D4
  • α2 adrenoceptors
  • GABAB receptors
36
Q

The phospholipase C pathway in activating PKC

A

GPCR gets activated, activating Gq (replacing its GDP with a GTP) and causing the alpha subunit to dissociate and activate phospholipase C which cleaves PIP2 into diacylglycerol (DAG) and IP3. DAG moves through the membrane and activates PKC and IP3 binds to IP3 receptors in the cytosol which release Ca²⁺ ions which bind to PKC and, with it fully activated, it can phosphorylate proteins and affect their function

37
Q

Receptors associated with Gi proteins

A
  • Muscarinic acetylcholine receptors M₁, M₃ and M₅
  • Histamine H1 receptor
  • Angiotensin II type 1 receptor
  • α1 adrenoceptors
38
Q

NHRs: what are they, what do they do, where are they found, how many of them are there, and what are the examples?

A

A superfamily of receptors that bind lipophilic substances (steroids etc) where their effects tend to be slower than other receptor types

Affect transcription rate of specific genes

Intracellular location (not in the membrane)

48 NHRs in man, all with a very similar structure to interact with either sex hormones or adrenal hormones (corticosteroids)

  • Progesterone, oestrogen, androgen receptors
  • Thyroid hormone receptor
  • Glucocorticoid, mineralocorticoid receptors
  • Vitamin D receptor
  • Retinoic acid receptors
39
Q

How do NHRs work?

A

Lipid soluble hormone passes through the membrane and interacts with the NHR in the cytosol, causing it to move into the nucleus where it affects the transcription rate of certain genes

40
Q

NHR structure

A

N-terminal - DNA binding domain (DBD) - Hinge region - Ligand binding domain (LBD) - C-terminal

41
Q

GCRs as NHRs (transactivation)

A

Glucocorticoid receptors are normally bound to heat shock proteins (HSP) but steroid interaction dissociates them and, normally, causes them to dimerize with other GCRs and enter the nucleus to interact with hormone response elements (HREs) which causes coactivator proteins to interact and increase transcription rates

42
Q

Transgression

A

Instead of dimerising, only the monomer binds to the HRE and, since it hasn’t dimerised, transcription does not progress (ns why)

This is only one possible mechanism

43
Q

Orphan receptors

A

NHRs/GCPRs that we do not know the function/ligand of

44
Q

Ion channels: what are they, what are their significant features, and what are examples?

A

Pores through the membrane which allow ions to pass through

Highly selective, very fast ion movement,

GABAₐ receptor

45
Q

Pumps: what are they, what are their significant features, and what are examples?

A

Membrane proteins which use active transport to move things through the membrane which may also manufacture ATP (ATP pumps)

Sodium-potassium ATPase

B1omed - Drugs: from molecules to man (1 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2025 Bold Learning Solutions. Terms and Conditions